Michigan lawmakers have introduced House Bill 4686, a proposal that would allow adults diagnosed with post-traumatic stress disorder (PTSD) to legally possess up to two ounces of psilocybin or psilocyn for personal therapeutic use. The bill also decriminalizes the cultivation, creation, manufacturing, or delivery of these substances for qualifying veterans and other PTSD patients.
Sponsored by seven legislators, including Rep. Mike McFall, the bill creates a clear exemption for adults over 18 who possess a medical record confirming a PTSD diagnosis. Participants would be legally protected when handling psilocybin in non-commercial, personal-use contexts.
This legislation follows interest in psilocybin therapy as an alternative treatment for veterans and others suffering from trauma-related conditions. Psilocybin has shown promising results in clinical trials, especially for individuals resistant to conventional therapies. Supporters argue that legal access through HB 4686 would improve mental health outcomes while reducing criminal penalties for those seeking relief.
Michigan has seen growing local support for psychedelics, with various cities already passing non-binding decriminalization measures. But HB 4686 would mark the first statewide law explicitly allowing therapeutic use based on a PTSD diagnosis—not just broad decriminalization.
The bill has been referred to the Families and Veterans Committee, where it will face debate and potential amendments. Key discussions are expected to cover topics like licensing, safety protocols, dosage limits, and integration of psilocybin therapy into existing medical systems.
If passed, Michigan will join a small but growing number of U.S. states offering legal therapeutic access—focused on veterans and trauma survivors. Advocates emphasize that proper regulations, medical supervision, and funding for education and harm-reduction are essential for implementing the law effectively and responsibly.
For more on topics like these, check this link out LATEST INDUSTRY NEWS
